Abstract 928: Variability in anthocyanin content among commercial blueberries and implications for dietary cancer prevention.

Abstract Early intervention through dietary cancer prevention may reduce tumor risk, as supported by experimental models and epidemiologic studies linking diet to lower cancer incidence. Mechanisms of cancer prevention for many edible fruits are mediated by bioactive phytonutrients. For example, consumption of two servings of blueberries per week was associated with a 25% lower cancer mortality among breast cancer patients in the Nurses' Health Study, and anthocyanin consumption was linked to a 22% reduced risk of colorectal cancer in a meta-analysis. Anthocyanins, a major class of bioactive flavonoids in blueberries, modulate endothelial growth and inhibit VEGF-driven angiogenesis in preclinical models, suggesting that differences in anthocyanin concentration across blueberry cultivars may influence their anticancer potential. Commercially grown blueberries are available in a variety of cultivars and regions, potentially resulting in substantial variability in anthocyanin content and bioactivity. To investigate this and identify candidates for mechanistic studies, blueberries were collected from 11 commercially available sources. Samples were frozen at -20°C, pulverized, solvent-extracted, and analyzed by high-performance liquid chromatography (HPLC) in triplicate, using cyanidin-3-0-glucoside (C3G) as a validated standard. Anthocyanin concentrations ranged from 0.204 to 4.244mg/g wet weight (C3G equivalents). Wild lowbush Maine blueberries contained the highest anthocyanin concentrations and had a distinct chromatographic profile, while highbush cultivars, which dominate U.S. commercial blueberry production, showed more variable levels, with several also ranking relatively high. Overall, these findings demonstrate that anthocyanin content differs significantly among blueberry types and provide a rationale for selecting specific cultivars for mechanistic studies of dietary angioprevention. Based on these results, representative extracts (high and low anthocyanin content) were selected for subsequent in vitro studies of endothelial tube formation. Such comparative biochemical characterization is essential to optimize the design of future investigations into the cancer-preventive potential of blueberry-derived anthocyanins. Citation Format: Noemi Y. Li, Lane Firestone, William W. Li, Vincent W. Li. Variability in anthocyanin content among commercial blueberries and implications for dietary cancer prevention [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 928.